We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IPA market cap is 33.07M. The company's latest EPS is CAD -1.0603 and P/E is -1.21.
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 5.18M | 5.17M | 5.62M | 5.69M | 6.15M |
| Operating Income | -12.68M | -4.58M | -6.08M | -4.18M | -3.03M |
| Net Income | -7.35M | -4.7M | -5.13M | -3.57M | -2.63M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 10.93M | 14.06M | 17.91M | 19.37M | 20.67M |
| Operating Income | -6.23M | -2.33M | -4.87M | -12.52M | -28.55M |
| Net Income | -7.62M | -4.95M | -7.34M | -16.71M | -26.56M |
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 82.75M | 82.44M | 77.81M | 76.58M | 75.61M |
| Total Liabilities | 21.01M | 21.36M | 20.01M | 22.74M | 23.58M |
| Total Equity | 61.74M | 61.08M | 57.8M | 53.85M | 52.03M |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 28.35M | 27.26M | 66.96M | 93.49M | 77.81M |
| Total Liabilities | 10.28M | 12.18M | 10.04M | 18.21M | 20.01M |
| Total Equity | 18.07M | 15.09M | 56.92M | 75.29M | 57.8M |
| Quarter End | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -14.06M | -17.6M | -19.83M | -702k | -937k |
| Investing | -1.3M | -1.52M | -1.97M | -197k | -509k |
| Financing | 42k | -240k | -621k | -405k | -715k |
| Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.21M | -1.39M | -600k | -9.92M | -19.83M |
| Investing | -2.2M | -1.58M | -2.46M | -5.21M | -1.97M |
| Financing | 9.35M | 174k | 43.38M | 2.88M | -621k |
| Market Cap | 33.07M |
| Price to Earnings Ratio | -1.21 |
| Price to Sales Ratio | 1.55 |
| Price to Cash Ratio | 3.87 |
| Price to Book Ratio | 0.55 |
| Dividend Yield | - |
| Shares Outstanding | 25.05M |
| Average Volume (1 week) | 70k |
| Average Volume (1 Month) | 89.62k |
| 52 Week Change | -48.64% |
| 52 Week High | 3.6047 |
| 52 Week Low | 0.94 |
| Spread (Intraday) | 0.12 (9.09%) |
| Company Name | ImmunoPrecise Antibodies Ltd |
| Address |
3204 – 4464 markham street victoria, british columbia V8Z 7X8 |
| Website | https://www.immunoprecise.com |
| Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
